Enoxaparin Sodium Injection
Product Images NDC 55154-9586

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 55154-9586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg Per 0.4ml, 5x0.4ml Single Dose Syringe Bag Label (45a66675 B159 42b8 9f18 Ff80f28e1503 00)

Text panel for Enoxaparin Sodium Injection USP 40 mg per 0.4 mL in single-dose syringes with automatic safety device. It includes directions for use, dosage form, storage conditions, warnings, manufacturer and distributor details, and instructions to activate the syringe's safety system after injection.*

FDA Label Image

Figure A (Eno0b 0003 01)

An instructional illustration showing two hands holding and pulling apart a syringe-like injection device, with a double-headed arrow indicating separation of the parts. The image likely demonstrates how to prepare or assemble the subcutaneous injection of Enoxaparin Sodium.*

FDA Label Image

Figure B (Eno0b 0003 02)

An instructional diagram labeled 'Figure B' illustrating a hand holding a syringe and a vial or similar container, with an arrow indicating the direction of drawing fluid into the syringe. The illustration appears to demonstrate how to withdraw medication for subcutaneous injection.*

FDA Label Image

Figure C (Eno0b 0003 03)

Illustration showing a hand holding an injection vial or cartridge, with an arrow indicating the direction to pull or slide a component. This diagram likely demonstrates part of the preparation or administration process for an injectable drug.*

FDA Label Image

Figure D (Eno0b 0003 04)

An instructional illustration labeled Figure D showing a hand holding a syringe with an arrow indicating the removal or ejection of the syringe cap. This image likely demonstrates a step in preparing the Enoxaparin Sodium injection for subcutaneous administration.*

FDA Label Image

Figure E (Eno0b 0003 05)

An instructional diagram labeled 'Figure E' showing a hand disposing of a syringe into a container marked with a biohazard symbol. The image emphasizes proper disposal of medical sharps in a biohazard waste container.*

FDA Label Image

Structural Formula (Eno0b 0003 06)

Chemical structure diagram of Enoxaparin Sodium, showing its polysaccharide components and repeating units with annotations for R1 and R2 functional groups.*

FDA Label Image

Structural Formula (Eno0b 0003 07)

Chemical structure of enoxaparin sodium, presented as a molecular diagram showing key ring systems and functional groups typical of this anticoagulant agent.*

FDA Label Image

Figure 1 (Eno0b 0003 08)

A forest plot chart comparing the relative risk of Enoxaparin Sodium injection versus UFH across various patient subgroups. The chart includes data for sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days. Each subgroup displays the number of patients, relative risk point estimates with confidence intervals, and percentage risk reductions favoring Enoxaparin or UFH.*

FDA Label Image

Figure 2 (Eno0b 0003 09)

A Kaplan-Meier hazard distribution function graph comparing Enoxaparin and UFH over 30 days for time to death or myocardial re-infarction. The graph shows the hazard increasing over time, with Enoxaparin consistently lower than UFH. A zoomed inset graph highlights cumulative hazard at 1 year, also showing Enoxaparin lower than UFH. Numbers at risk for both treatments are listed below the x-axis.*

FDA Label Image

Fresenius Kabi Logo (Eno0b 0003 10)

Enoxaparin Sodium 40 mg/0.4 mL injection, presented in a single-dose prefilled syringe package. The label shows the product name, strength, dosage form, administration route (subcutaneous), and the labeler, Cardinal Health 107, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.